We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine.
SAN CARLOS, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the...
-- Company Expects to Announce Topline Safety, Tolerability and Immunogenicity Data from Primary Immunization Series by the End of the First Quarter of 2025, Followed by Topline Data from Booster...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -3.51 | -5.4553932235 | 64.34 | 64.56 | 59.39 | 704506 | 61.9283386 | CS |
4 | -7.26 | -10.662358643 | 68.09 | 69.685 | 59.39 | 602186 | 64.33146415 | CS |
12 | -3.19 | -4.98281786942 | 64.02 | 82.04 | 59.39 | 857310 | 71.08732957 | CS |
26 | 14.69 | 31.8378846987 | 46.14 | 82.04 | 45 | 756778 | 64.04615612 | CS |
52 | 16.97 | 38.6912904697 | 43.86 | 82.04 | 41.57 | 724821 | 56.7531973 | CS |
156 | 42.59 | 233.497807018 | 18.24 | 82.04 | 15.51 | 560214 | 43.1968796 | CS |
260 | 37.27 | 158.191850594 | 23.56 | 82.04 | 15.51 | 500248 | 41.74716197 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions